Logo image of XLNX

XILINX INC (XLNX) Stock Fundamental Analysis

NASDAQ:XLNX - Nasdaq - Common Stock

194.92  -21.63 (-9.99%)

After market: 193.05 -1.87 (-0.96%)

Fundamental Rating

3

Taking everything into account, XLNX scores 3 out of 10 in our fundamental rating. XLNX was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of XLNX have multiple concerns. XLNX is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

XLNX had positive earnings in the past year.
XLNX Yearly Net Income VS EBIT VS OCF VS FCFXLNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

1.2 Ratios

Industry RankSector Rank
ROA 14.64%
ROE 25.28%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XLNX Yearly ROA, ROE, ROICXLNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 10 20 30

1.3 Margins

Industry RankSector Rank
OM 26.39%
PM (TTM) 25.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XLNX Yearly Profit, Operating, Gross MarginsXLNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

XLNX has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, XLNX has a worse debt to assets ratio.
XLNX Yearly Shares OutstandingXLNX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M
XLNX Yearly Total Debt VS Total AssetsXLNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B 5B

2.2 Solvency

XLNX has an Altman-Z score of 13.19. This indicates that XLNX is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.41 indicates that XLNX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 13.19
ROIC/WACCN/A
WACCN/A
XLNX Yearly LT Debt VS Equity VS FCFXLNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

XLNX has a Current Ratio of 6.62. This indicates that XLNX is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 6.13 indicates that XLNX has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 6.62
Quick Ratio 6.13
XLNX Yearly Current Assets VS Current LiabilitesXLNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.98% over the past year.
Measured over the past 5 years, XLNX shows a small growth in Earnings Per Share. The EPS has been growing by 4.85% on average per year.
Looking at the last year, XLNX shows a very strong growth in Revenue. The Revenue has grown by 20.43%.
XLNX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.29% yearly.
EPS 1Y (TTM)45.98%
EPS 3Y-2.2%
EPS 5Y4.85%
EPS Q2Q%86.96%
Revenue 1Y (TTM)20.43%
Revenue growth 3Y8.46%
Revenue growth 5Y7.29%
Sales Q2Q%25.85%

3.2 Future

The Earnings Per Share is expected to grow by 19.30% on average over the next years. This is quite good.
The Revenue is expected to grow by 11.09% on average over the next years. This is quite good.
EPS Next Y57.65%
EPS Next 2Y30.1%
EPS Next 3Y25.35%
EPS Next 5Y19.3%
Revenue Next Year23.37%
Revenue Next 2Y16.28%
Revenue Next 3Y13.42%
Revenue Next 5Y11.09%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XLNX Yearly Revenue VS EstimatesXLNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B 5B
XLNX Yearly EPS VS EstimatesXLNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 51.16, which means the current valuation is very expensive for XLNX.
XLNX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.18.
The Price/Forward Earnings ratio is 44.12, which means the current valuation is very expensive for XLNX.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.81, XLNX is valued quite expensively.
Industry RankSector Rank
PE 51.16
Fwd PE 44.12
XLNX Price Earnings VS Forward Price EarningsXLNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.69
XLNX Per share dataXLNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

XLNX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XLNX's earnings are expected to grow with 25.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)10.56
EPS Next 2Y30.1%
EPS Next 3Y25.35%

More info and screens

4

5. Dividend

5.1 Amount

XLNX has a yearly dividend return of 0.76%, which is pretty low.
With a Dividend Yield of 0.76, XLNX pays less dividend than the S&P500 average, which is at 2.45.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

The dividend of XLNX has a limited annual growth rate of 2.55%.
XLNX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)2.55%
Div Incr YearsN/A
Div Non Decr YearsN/A
XLNX Yearly Dividends per shareXLNX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.5 1 1.5

5.3 Sustainability

9.87% of the earnings are spent on dividend by XLNX. This is a low number and sustainable payout ratio.
The dividend of XLNX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP9.87%
EPS Next 2Y30.1%
EPS Next 3Y25.35%
XLNX Yearly Income VS Free CF VS DividendXLNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B
XLNX Dividend Payout.XLNX Dividend Payout, showing the Payout Ratio.XLNX Dividend Payout.PayoutRetained Earnings

More info and screens

XILINX INC

NASDAQ:XLNX (2/11/2022, 8:00:02 PM)

After market: 193.05 -1.87 (-0.96%)

194.92

-21.63 (-9.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)02-08 2022-02-08/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners0.17%
Ins Owner Change0%
Market Cap48.41B
Analysts67.2
Price Target192.41 (-1.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend1.51
Dividend Growth(5Y)2.55%
DP9.87%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 51.16
Fwd PE 44.12
P/S 13.17
P/FCF N/A
P/OCF N/A
P/B 13.18
P/tB N/A
EV/EBITDA 39.69
EPS(TTM)3.81
EY1.95%
EPS(NY)4.42
Fwd EY2.27%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS14.8
BVpS14.79
TBVpSN/A
PEG (NY)0.89
PEG (5Y)10.56
Profitability
Industry RankSector Rank
ROA 14.64%
ROE 25.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 26.39%
PM (TTM) 25.26%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.62
Quick Ratio 6.13
Altman-Z 13.19
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.98%
EPS 3Y-2.2%
EPS 5Y4.85%
EPS Q2Q%86.96%
EPS Next Y57.65%
EPS Next 2Y30.1%
EPS Next 3Y25.35%
EPS Next 5Y19.3%
Revenue 1Y (TTM)20.43%
Revenue growth 3Y8.46%
Revenue growth 5Y7.29%
Sales Q2Q%25.85%
Revenue Next Year23.37%
Revenue Next 2Y16.28%
Revenue Next 3Y13.42%
Revenue Next 5Y11.09%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A